Skip to content

Alto Neuroscience ANRO Retained Earnings

Retained Earnings at other companies

Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$1.35B-39.7%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
-$1.81B+17.2%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-$255.09M-72.6%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-$1.23B-36.0%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$862.54M-16.2%
LBR
LB Pharmaceuticals Inc Common StockLBRX
-$148.58M

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$887.88M+1,358%
Enterprise value$644.49M-958%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's retained earnings?
Alto Neuroscience (ANRO) reported retained earnings of -$227.87M in Q1 2026.
How has Alto Neuroscience's retained earnings changed year-over-year?
Alto Neuroscience's retained earnings decreased by 48.4% year-over-year, from -$153.57M to -$227.87M.
What is the long-term trend for Alto Neuroscience's retained earnings?
Over 2 years (2023 to 2025), Alto Neuroscience's retained earnings has grown at a 61.9% compound annual growth rate (CAGR), from -$76.97M to -$201.63M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.